3T Biosciences Announces Appointment of John Leonard, M.D. to its Board of Directors

Current president and CEO of Intellia Therapeutics and previous global head of Abbvie’s R&D brings more than 30 years’ experience leading discovery, development, and launch of groundbreaking blockbuster medicines SAN FRANCISCO, Calif., Oct. 25, 2022 /PRNewswire/ — 3T Biosciences (“3T”),…

About the Author

has written 20652 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com